Status:
COMPLETED
Examination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Pregnancy Complications
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Urinary tract infection is the most common bacterial infection during pregnancy. Asymptomatic bacteriuria is the most common infection, in up to 8% of the population. Symptomatic infection may cause c...
Detailed Description
During pregnancy functional modifications in the urinary tract influence the function of the urinary tract system. Those changes raise the risk of urinary tract infections. The most common bacterial i...
Eligibility Criteria
Inclusion
- Pregnant women with two or more episodes of bacteriuria or one episode of pyelonephritis during pregnancy.
Exclusion
- Women with malformations of the urinary tract
- women with risk factors to urinary tract infections, for example DIABETES MELLITUS, REFLUX.
- Women with urinary tract infection caused by resistant bacteria (to conventional treatment)
Key Trial Info
Start Date :
January 16 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01507974
Start Date
January 16 2012
End Date
January 1 2015
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep of OG/GYN, Emek Medical Center
Afula, Israel